The World Congress on Precision Biotherapeutics is guided by an international committee of distinguished researchers, clinicians, track chairs, and peer-review editors dedicated to scientific excellence and translational impact.
Biography:
Pioneer in site-specific antibody conjugation technologies and next-generation clinical translation. Author of over 240 peer-reviewed papers on immunotherapy efficacy, payload chemistry, and linker stability.
Biography:
Specialist in nanomedicine delivery kinetics and lipid nanoparticle (LNP) formulation for targeted mRNA therapeutic transport and non-viral cellular uptake.
Biography:
asfdasfd asfda a sfasdf asdf asdf asdfa sfasd asdfasd fasdf asdf asdfasd fasdfasdf asdfa sdfasdf asdf asdfas dfasdf asdfas dfasd asdfa sdfa
Biography: Directs research on synthetic siRNA structural stability, RNA-editing oligonucleotides, and ADC payload mechanisms. Coordinates peer review for tracks T1 & T2.
Biography: Expert in machine learning models for protein docking, generative de novo binder design, and clinical CRISPR gene editing delivery safety protocols.
Biography:
Manages open-access peer-review standards and coordinates special thematic congress issues in JPB for outstanding WCPB research findings.
Biography: Specializes in liquid biopsy validation, companion diagnostics for targeted therapies, and phase II/III biomarker evaluation protocols.